 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Denali Therapeutics Inc. (DNLI)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-22 Sale | 2019-11-26 5:08 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 15,000 | $18.02 | $270,287 | 584,378 (Indirect Direct) | View |
| 2019-11-22 Sale | 2019-11-26 6:17 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 43,485 | $18.02 | $783,574 | 2,450,572 (Indirect Direct) | View |
| 2019-12-03 Sale | 2019-12-05 4:29 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 21,268 | $18 | $382,874 | 2,429,304 (Indirect Direct) | View |
| 2019-12-03 Sale | 2019-12-05 5:16 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 7,500 | $18 | $135,017 | 25,839 (Indirect Direct) | View |
| 2019-12-19 Sale | 2019-12-23 7:35 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 6,890 | $20.01 | $137,835 | 0 (Indirect Direct) | View |
| 2020-02-26 Sale | 2020-02-28 4:25 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 3,894,764 | $20.25 | $78,868,971 | 15,567,736 (Indirect) | View |
| 2020-03-30 Sale | 2020-04-01 6:17 pm | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 4,807 | $19.48 | $93,640 | 22,013 (Indirect Direct) | View |
| 2020-03-30 Sale | 2020-04-01 6:18 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,428 | $19.48 | $27,817 | 2,822 (Indirect Direct) | View |
| 2020-03-30 Sale | 2020-04-01 6:19 pm | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,427 | $19.49 | $27,812 | 28,662 (Indirect Direct) | View |
| 2020-03-30 Sale | 2020-04-01 6:19 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,428 | $19.48 | $27,817 | 1,006,488 (Direct) | View |
| 2020-06-05 Sale | 2020-06-09 4:10 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,922,855 | $25.75 | $49,513,516 | 13,644,881 (Indirect) | View |
| 2020-06-16 Sale | 2020-06-18 9:41 pm | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 400,000 | $26.1 | $10,440,000 | 2,739,043 (Direct) | View |
| 2020-06-19 Sale | 2020-06-23 5:41 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 255,000 | $24.72 | $6,304,373 | 698,035 (Indirect) | View |
| 2020-06-26 Sale | 2020-06-30 7:17 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 250,000 | $23.97 | $5,993,052 | 448,035 (Indirect) | View |
| 2020-08-12 Sale | 2020-08-14 4:50 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,443,247 | $31.65 | $45,678,767 | 12,201,634 (Indirect) | View |
| 2020-09-10 Sale | 2020-09-14 9:38 pm | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 3,689 | $31 | $114,359 | 165,141 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 711 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 3,121 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 711 | $5.28 | 25,839 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 5:16 pm | N/A 2027-03-07 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 3,121 | $5.28 | 25,839 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:01 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 29,874 | $0 | 142,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:01 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 142,000 | $24.81 | 142,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 78,787 | $0 | 367,675 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:02 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 367,675 | $24.81 | 367,675 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 29,143 | $0 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 136,000 | $24.81 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 29,143 | $0 | 136,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:03 pm | N/A 2030-02-09 | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 136,000 | $24.81 | 136,000 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 5,515 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 8,800 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 5,515 | $0 | 26,400 (Direct) | View |
| 2020-02-08 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 8,800 | $0 | 26,400 (Direct) | View |
| 2019-02-07 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,250 | $0 | 12,750 (Direct) | View |
| 2019-02-07 Exercise | 2020-04-01 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:15 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:15 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-02-07 Exercise | 2020-04-01 6:16 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 4,250 | $0 | 12,750 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:58 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:58 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:59 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:59 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:00 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:01 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:01 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Klein Peter S Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | NELSEN ROBERT Director 10% Owner | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:02 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schenkein David P Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:03 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 15,183 | $28.82 | 3,253 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:03 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | SATO VICKI L Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2020-06-18 Gift | 2020-06-18 9:42 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 40,000 | $0 | 2,389,304 (Indirect) | View |
| 2020-08-18 Option Award | 2020-08-20 6:14 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Watts Ryan J. CEO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:17 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:19 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-18 Option Award | 2020-08-20 6:20 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 0 (Indirect) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 1,954 | $32.87 | 0 (Indirect) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 0 (Indirect) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 1,954 | $32.88 | 0 (Indirect) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 0 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 1,954 | $32.88 | 0 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:38 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer | 5,643 | $0 | 0 (Direct) | View |